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Abstract
A novel method for the production of important medical radioisotopes has been developed. The approach is based on performing
the nuclear reaction in inverse kinematics, namely sending a heavy-ion beam of appropriate energy on a light target (e.g. H, d, He)
and collecting the isotope of interest. In this work, as a proof-of-concept, we studied the production of the theranostic radionuclide
67Cu (T1/2=62 h) via the reaction of a
70Zn beam at 15 MeV/nucleon with a hydrogen gas target. The 67Cu radionuclide, alongside
other coproduced isotopes, was collected after the gas target on an Al catcher foil and their radioactivity was measured by off-
line γ-ray analysis. After 36 h from the end of the irradiation, apart from the product of interest 67Cu, the main radioimpurity
coming from the 70Zn+p reaction was 69mZn (T1/2=13.8 h) that can be reduced by further radio-cooling. Moreover, along with
the radionuclide of interest produced in inverse kinematics, the production of additional radioisotopes is possible by making use of
the forward-focused neutrons from the reaction and letting them interact with a secondary target. A preliminary successful test of
this concept was realized in the present study. The main requirement to obtain activities appropriate for preclinical studies is the
development of high-intensity heavy-ion primary beams.
Keywords:
1. Introduction
Medical radionuclides play a central role in nuclear medicine
in the fields of diagnostic imaging and radioimmunotherapy
(RIT) (Qaim (2017); Srivastava (2014); Stocklin (1995)). Ra-
dionuclides emitting low-range highly ionizing radiation ( β− or
α particles, Auger or conversion electrons) are essential for RIT
approaches. Apart from a number of standard radionuclides,
currently the β− emitters 47Sc (T1/2=3.4 d),
67Cu (T1/2=2.6 d),
105Rh (T1/2=1.5 d),
161Tb (T1/2=6.9 d) and
186Re (T1/2=3.7 d)
(Champion (2016); Qaim (2017)) are increasingly interesting.
Specifically, 67Cu, the longest-lived radioisotope of copper,
is ideally suited for both radioimmunotherapy and imaging
for several reasons (Asabella (2014)). First, from a chemi-
cal perspective, copper is an essential trace element for most
organisms and specifically for humans as it takes part in im-
portant biochemical processes (Linder (1991)). The coordina-
tion chemistry of Cu has been well established (Price (2014)).
Copper can be linked to antibodies, proteins and other bio-
logically important molecules (Follacchio (2018); Ting (2009);
Schubiger (1996); Sugo (2017)). The nuclide 67Cu can be
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combined with the same type of radiopharmaceuticals as 64Cu
(T1/2=12.7 h) or
61Cu (T1/2=3.3 h) leading to efficient thera-
nostic pairs (Zimmerman (2003)).
The half-life of 67Cu (62 h) is appropriate to deliver a high
dose rate to the tumor. Furthermore, its β− decay (Ee,ave =
141 keV) is followed by the emission of soft γ radiation of
185 keV (48.7%), 93 keV (16%) and 91 keV (7%). This
makes 67Cu suitable for imaging the radiotracer distribution by
single-photon emission computed tomography (SPECT) using
the cameras widely developed for the 140 keV γ rays of 99mTc.
Compared to the standard RIT radioisotope 90Y (T1/2=64 h,
Ee,max=2.28 MeV), which is a pure β
− emitter, 67Cu offers the
possibility of SPECT imaging and treatment of smaller size tu-
mors (up to 4 mm, compared to 12 mm in the case of 90Y).
In addition, 67Cu compares favorably with another standard ra-
dioisotope, 131I (T1/2=8.0 d, Ee,max=0.61 MeV), which has a
longer half-life and emits higher energy γ rays (0.364 MeV,
82%) and thus, may increase the undesired dose to the patient
and the medical personnel.
It is noteworthy that while the other radioisotopes of cop-
per, especially 64Cu, have already been used in radiopharma-
ceuticals for a wide range of preclinical and clinical studies
(Follacchio (2018); Peng (2006)), 67Cu has been used in a rather
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limited number of studies, albeit with very promising results
(Jin (2017); Katz (1990); Knogler (2007); Novak (2002)). The
main factor limiting the wider preclinical and clinical use is its
limited availability (Smith (2012)).
The production of 67Cu in nuclear reactors started about
50 years ago (O’Brien (1969)) and continues until present
in several reactor facilities (e.g. Johnsen (2015); Uddin
(2014); Mirzadeh (1986)). Recently, however, the main fo-
cus has shifted to methods based on particle accelerators (Smith
(2012)). Presently, the main production route is via the reaction
68Zn(p,2p)67Cu (Katabuchi (2008); Medvedev (2008); Pupillo
(2018); Stoll (2002)). This approach is based on the use of in-
tense medium-energy (Ep=70–100MeV) proton beams that are
available by several particle accelerators, including medium-
energy cyclotrons. However, these multipurpose facilities can-
not dedicate all their beam time to radioisotope production.
Other production routes based on lower-energy charged par-
ticle reactions are 70Zn(p,α)67Cu (Hilgers (2003); Jamriska
(1995); Kastleiner (1999)), 70Zn(d,αn)67Cu (Kozempel (2012))
and natZn(d,x)67Cu (Hosseini (2017)), 64Ni(α,p)67Cu (Ohya
(2018); Skakun (2004)). Moreover, production routes based
on reactions induced by accelerator-produced neutrons have
been applied (Kawabata (2015); Kin (2013); Sato (2014);
Spahn (2004)). In addition, 67Cu has been produced in pho-
tonuclear reactions using bremsstrahlung photons from high-
intensity electron linacs (Gopalakrishna (2018); Starovoitova
(2014, 2015); Yagi (1978)).
Finally, isotope harvesting in projectile fragmentation facili-
ties has been suggested as an alternative source of medical iso-
topes. A proof-of-concept was presented in the recent work
by Mastren et al. (Mastren (2014, 2015)) at the NSCL. This
work involved harvesting and separation of 67Cu from amixture
of projectile fragments stopped in an aqueous beam-collection
system. The 67Cu radionuclide separation was followed by ra-
diolabelling and biodistribution studies.
A general characteristic of all the previous production meth-
ods is the fact that the desired radioisotope of 67Cu is produced
inside the target material which can be moderately or highly ex-
pensive, depending on the setup and approach. In regard to the
production of 67Cu, the natural abundance of 68Zn is 18.45%,
70Zn is 0.61% and 64Ni is 0.93%. Thus, in these cases, an ef-
ficient analysis scheme is necessary for the collection of the
desired 67Cu isotope and the recovery of the target material for
subsequent re-use in the production scheme (Smith (2012)).
Along with this traditional scheme, in the isotope-harvesting
route, the isotope of interest has to be separated from a
very broad range of radioisotopes of other elements that are
abundantly coproduced in a projectile fragmentation reaction.
Thus, an appropriate multistep separation process is necessary
(Mastren (2015)).
In this paper, we present an innovative approach for the pro-
duction of medical radioisotopes based on inverse-kinematics
nuclear reactions, that is, sending a heavy-ion beam on a light
target and collecting the radioisotope after the target. The main
advantage of using an inverse kinematics reaction is that the
products are strongly focused along the beam direction and,
thus, can be easily collected for immediate use.
Proof-of-principle of the aforementioned approach is pre-
sented for the production of 67Cu via the reaction of a 70Zn
beam at 15 MeV/nucleonwith a hydrogen gas target. This work
demonstrates that important non-standard medical radioiso-
topes with high radionuclide purity can be produced, provided
that low-energy and high-intensity primary beams are available.
Our method has some similarity with the isotope-harvesting ap-
proach from fragmentation facilities, in the sense that, in the
latter, the fragmentation reactions also occur in inverse kine-
matics, albeit at high energies (above 100 MeV/nucleon) pro-
ducing a very broad range of isotopes. The inverse kinematics
approach, however, takes place at low energy. By choosing the
appropriate reaction channel, the radionuclide of interest can
be selectively produced with minimal radioimpurities and im-
planted in an appropriate catcher material for subsequent use
(after minimal radiochemical processing if necessary). In paral-
lel, the forward-focused neutrons from the primary reaction can
be sent to a secondary target for additional radioisotope produc-
tion.
The structure of the paper is as follows: in section 2, we
present the experimental setup and the measurements; in sec-
tion 3, we continue with the data analysis and the results. In
section 4, we discuss improvements of the present method and
further plans. Finally, in section 5, we provide a summary and
conclusions.
Figure 1: (Color online) The cryogenic gas target cell used in the present work
(Brinkley (2003)).
2. Experimental Setup and Measurements
The experimental work took place at the Cyclotron Insti-
tute of Texas A&M University (TAMU). A primary beam of
70Zn15+ from the ECR source was accelerated by the K500 su-
perconducting cyclotron to an energy of 15 MeV/nucleon and
transported to the target chamber of the MARS recoil separator
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Figure 2: (Color online) Schematic diagram of the irradiation setup. A 70Zn beam at 15 MeV/nucleon enters the gas cell and interacts with the hydrogen gas.
The heavy reaction products, including 67Cu, after exiting the gas cell are implanted in the Al catcher. The energies of the beam are listed as it passes through the
entrance window, the gas and the exit window (thick red arrows). The dashed (green) arrows represent the neutrons produced via the interactions of the 70Zn beam
with the hydrogen gas and the Al catcher. For details, see sections 2, 3.2 and 3.3.
(Tribble (1989)). The beam impinged on a cryogenic gas cell
filled with H2 gas held at a pressure of 2.7 atm in contact with a
liquid nitrogen reservoir (Brinkley (2003)). The cryogenic gas
cell (figure 1) has a length of 10 cm with 4 µm Havar entrance
and exit windows of 19.0 mm diameter. The experimental setup
is schematically shown in figure 2. An aluminum foil, mounted
on an aluminum target frame (with a hole of 12.7 mm) placed
after the hydrogen gas cell, was used to collect the produced
67Cu nuclei from the reaction of the 70Zn beam with the proton
target. The irradiation lasted 6.5 h with a beam current of 0.31
pnA (particle nA) (2.0×109 particles s−1). The current was peri-
odically monitored and was nearly constant (within 15 %). The
measurement of the current was performed by inserting a Fara-
day cup mounted on the same target ladder as the Al catcher
frame. The measurement of the beam current at this location
(i.e. after the gas cell) was 8.0 nA of 70Zn (7.0 MeV/nucleon)
at an average charge state of 26+. This equilibrium charge state
value was calculated with the parametrization of Leon et al.
(Leon (1998)). After 36.4 h from the end of the irradiation,
the Al catcher foil was moved in front of a high-purity germa-
nium (HPGe) detector for off-line γ-ray analysis as described
in the following sections.
3. Data analysis and results
3.1. Off-line γ-ray analysis
The radioactivity of the produced 67Cu and the other copro-
duced radioisotopes was determined by off-line analysis of the
γ-ray spectra. The foil was placed at a distance of d = 17.2(10)
mm from the end cap of the detector. Under this condition, the
dead time of the counting system was around 2-3%, thus avoid-
ing the pile-up effect. The energy resolution of the detector
system was 2.5–4.0 keV FWHM.
The energy calibration was performed using known γ-rays
obtained in the spectra. The absolute efficiencies were obtained
using photopeak efficiency predictions generated from a Geant4
(Agostinelli (2003)) simulation, considering the source and the
detector geometry. The spectrum of the room background was
measured for 67.3 h.
The radioactivity levels of the isotopes were determined by
the quantification of the photopeaks of the γ-rays taking into
account the branching ratios and the absolute efficiencies of the
detector. A detailed description of the γ-ray analysis of all the
observed γ-ray peaks will be presented in Rodrigues (2019).
In figure 3, we present the background-subtractedγ-ray spec-
trum obtained during an accumulation period of 68.0 h, starting
36.4 h after the end of the irradiation. We note that the peaks
at 92 keV and 185 keV are characteristic of 67Cu decay. The
peak at 439 keV is due to the main radioimpurity of 69mZn (T1/2
=13.8 h) from the 70Zn+p reaction. We observe a small contri-
bution, around 3% of the 67Cu production, from γ-ray at 300.2
keV characteristic of the presence and decay of 67Ga (T1/2=78
h) with a branching ratio of 16.7%. We note that this radioimpu-
rity, decaying to the same levels of 67Zn as 67Cu, is intensely co-
produced in the main production route via 68Zn(p,2p)67Cu with
high energy protons (Smith (2012)). This γ-ray for 67Cu has a
branching ratio of only 0.8%. Similarly, the peak at 1115.5 keV,
characteristic of 65Zn (T1/2 =244 d), is significantly suppressed
(0.2% of the 67Cu production). This radionuclide is notoriously
produced in the high-energy 67Cu production methods and re-
quires radiochemical separation.
In the spectrum of figure 3, we observe peaks from a se-
ries of radionuclides that are mainly due to nuclear reactions on
the Havar windows and the Al catcher foil. More specifically,
the radionuclides 86Y, 87Y, 89Zr, 90Nb and 93mMo are fusion-
evaporation products of the reaction 70Zn+27Al (with the beam
of 70Zn entering the Al catcher at 7.0 MeV/nucleon, see section
3.2). Furthermore, the heavier radionuclides 111In, 117mSn and
119Te are residues of the reaction of the 70Zn beamwith the con-
stituents of the Havar alloy (42% Co) of the gas-cell windows.
We also identified the presence of 7Be (T1/2=53 d, Eγ=477.6
keV) possibly coming from the activation of the small Be or C
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Figure 3: (Color online) Typical background-subtracted gamma-ray spectrum of the Al catcher foil following the interaction of a 70Zn (15 MeV/nucleon) beam
with the hydrogen gas cell after 36.4 h from the end of the irradiation. The peaks are labelled with the corresponding radionuclides (see text). We specifically note
the two peaks (at 92 keV and 185 keV) due to 67Cu. and the peak (at 439 keV) due to 69mZn (T1/2 =13.8 h), which is the main radioimpurity coming from the
production reaction 70Zn+p.
content of the Havar alloy (0.02–0.08%, 1.6%, respectively). A
complete analysis of the origin and the activity of these radionu-
clides will be presented in (Rodrigues (2019)). As we discuss
in section 3.2, the radioimpurities coming from the Havar win-
dows and the Al catcher can be easily reduced or completely
eliminated by proper tuning of the energy loss of the primary
beam in the gas cell, so they do not present a potential problem
in the proposed method of radionuclide production.
From the above analysis, the activity of the produced 67Cu at
the end of the 6.5 h of irradiation was 1.6(5) kBq with the beam
current of 0.31 pnA. This leads to a specific activity of 0.8(3)
kBq/h/pnA (or equivalently, 0.8(3) MBq/h/pµA).
Along with the activity of 67Cu, we report the measured ac-
tivity of 0.094 kBq of the 69mZn (T1/2 =13.8 h) at the end of
the irradiation (this corresponds to a specific activity of 0.045
kBq/h/pnA). This is a rather low activity that can be further re-
duced by an appropriate cooling period (of, e.g., 2 days).
3.2. Comparison of measured 67Cu activity with estimates
In this section, we estimate the activity of the radionuclide
67Cu produced in the inverse kinematics reaction 70Zn (15
MeV/nucleon) + p. The cross sections for the direct kine-
matics reaction 70Zn(p,α)67Cu have been reported in Kastleiner
(1999). We take into account that the 10 cm long gas target cell
was filled with H2 gas at a pressure of 2.7 atm and was at a
temperature of 87 K via the thermal contact with the LN2 De-
war. Under these conditions, the H2 gas target thickness was
7.5 mg/cm2. Using the code SRIM (Ziegler (2013)), we cal-
culated the energy losses of the beam in the entrance window,
the gas and the exit window of the gas cell. The 70Zn beam
hit the entrance window at 15 MeV/nucleon, exited it at 14.2
MeV/nucleon, traversed the gas and reached the exit window
at 8.0 MeV/nucleon and, finally exited it at 7.0 MeV/nucleon
(figure 2).
Using the data of Kastleiner et al. (Kastleiner (1999)), we
estimated the integral of the excitation function in the region
14.2–8.0 MeV, resulting in an average value for the cross sec-
tion of 7.5 mb for 67Cu. Using this cross section value and
the H2 gas target thickness, we obtained the production rate of
67Cu. Subsequently, we obtained the produced activity, assum-
ing 1h of irradiation with a beam intensity of 1 pnA. This ac-
tivity is calculated to be 1.8 kBq/h/pnA (or equivalently, 1.8
MBq/h/pµA). We notice that the measured activity of 0.8(3)
kBq/h/pnA is about 2.2 times lower that the expected activity,
as obtained with the procedure described above.
In this section, we discuss several possible sources for the
discrepancy between the experimental and the theoretical activ-
ity of 67Cu: a) the spread of the recoiling 67Cu nuclei that may
result in an incomplete collection on the Al catcher foil. As
previously mentioned, the Al foil was mounted on an Al frame
with a 12.7 mm hole. The 67Cu activity of the target frame was
measured to be 0.12 kBq which is 7.5% of the main activity
collected on the Al catcher foil; b) the use of an unsuppressed
Faraday cup to measure the beam current. As it is well known,
the sputtering of electrons from the side of the Faraday cup hit
by the heavy-ion beam results in an increase of the measured
positive current leading to a lowering of the obtained produc-
tion rate and, thus, the specific activity. The cup should be bi-
ased to a positive voltage (in the range 200–400V). Such elec-
tron suppression of the Faraday cup was not performed in the
present experiment. This effect may account for about 20–30%
of the discrepancy, but it should be quantified for the present
heavy-ion setup (as performed in Carzaniga (2017), figure 4,
for proton beams); c) the reduction of the pressure of the H2
gas due to local heating along the path of the primary beam. As
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reported in a previous study (Brinkley (2003)), this effect has
been observed in the behavior of this gas cell during its use for
radioactive beam production with the MARS recoil separator.
The rate of radioactive beams has been observed to drop when
intense primary beams were used, but no quantitative estimates
have been reported. A related quantitative account of this effect
is reported by Amadio et al. (Amadio (2008)) for the produc-
tion of a low-energy radioactive beam of 7Be in a cryogenic hy-
drogen gas cell. In that setup, circulation of the hydrogen gas
cooled at LN2 temperature indicated that the effect of the lo-
cal pressure reduction may amount to 60–70% at high primary
beam currents [figure 4 of (Amadio (2008))]. Similar measure-
ments are necessary for the present gas cell. We note that a
magnetic stirring system was operated in this cell, but its effect
was rather inadequate.
Finally, we mention that, by using the cross section data of
(Kastleiner (1999)), the production cross section of 67Cu drops
to nearly zero at about 7 MeV. Thus, in the energy range 14.2–
8.0 MeV/nucleon of the 70Zn beam in the hydrogen gas, almost
the full thickness of the target was exploited to produce 67Cu.
3.3. Use of the neutrons from the primary reaction for sec-
ondary radioisotope production
The interaction of 70Zn at 15 MeV/nucleon with the pro-
ton target produces about 1.6 neutrons per reaction, as calcu-
lated with the code TALYS (Koning (2012); Duchemin (2015)).
Along with the heavy reaction products, these neutrons are also
kinematically focused in the forward direction and can be ex-
ploited for further radioisotope production by simply letting
them interact with a secondary target, e.g., a 68Zn or natZn target
for additional production of 67Cu. In this work, we performed
such a test by placing a block of twenty 25.4x25.4 mm2 foils of
natZn with 1 mm thickness behind the Al catcher (figure 2).
Because this production is from the secondary neutrons, the
yield is expected to be about 2 orders of magnitude lower
than the main production channel. However, given the long
mean free path of the neutrons (with a typical value of sev-
eral cm), production of different isotopes is conceivable with
these neutrons impinging on different targets. This production
scheme shares some similarity with the one recently published
in (Auditore (2017)) employing secondary neutrons from the
target of a standard 18F radioisotope-producing setup. The ad-
vantage of our approach of inverse kinematics is the strong fo-
cusing of the secondary neutrons that can be directed to a tar-
get stack of much smaller size than the one used in (Auditore
(2017)), which essentially encloses the target. The results of
our neutron-production test are promising. The analysis work is
currently in progress and will be presented in Rodrigues (2019).
4. Discussion and plans
The present preliminary study that we performed at the Cy-
clotron Institute of TAMU confirms that important medical ra-
dionuclides, such as 67Cu, can be effectively produced using
inverse kinematics. The main advantages of the present novel
approach along with necessary developments and relevant im-
plementations are discussed below.
First, the produced radionuclides are strongly focused along
the beam direction and, thus, can be easily collected. In this
respect, with the appropriate choice of the reaction channel(s)
and the subsequent cooling time of the products, it is possi-
ble to minimize the production of radioimpurities coming from
the main reaction. Moreover, it is possible to minimize the ra-
dioimpurities resulting from the primary beam interacting with
the Havar windows of the gas target and the catcher material.
Of course, we cannot avoid reactions at the entrance window,
where the beam enters with the full energy of 15 MeV/nucleon
and induces reactions on the foil. However, the products com-
ing from peripheral or semiperipheral (deep-inelastic) colli-
sions on the isotopes of Havar (Co, Cr, Ni, W, etc.) have
rather wide angular distributions [e.g., (Fountas (2014)) and
(Papageorgiou (2018)) figure 4] and are expected to mostly
miss the catcher (depending on its diameter). On the other hand,
the products of complete or nearly complete fusion are forward
focused, but are heavier and slower than the beam and, thus,
may mostly stop in the gas.
Regarding the exit window, it is possible to adjust the gas
cell parameters (pressure, temperature and length) so that the
primary beam reaches this window at low energy, i.e. near or
below the Coulomb barrier of the relevant reactions (e.g., 4.0
MeV/nucleon). Consequently, nuclear reactions can be sup-
pressed or fully eliminated on that window. Of course, under
these conditions, the low energy primary beam exiting the gas
cell will not induce reactions in the catcher material. For exam-
ple, referring to the 70Zn+27Al reaction, the Coulomb barrier
corresponds to a projectile energy of 3.5 MeV/nucleon. We
realize that detailed simulations and further experimental tests
are necessary to achieve optimum conditions for the experimen-
tal setup and production procedure. Under properly fine-tuned
conditions, water or other materials (salt, sugar, etc.) can be
used to collect the radioisotopes in a convenient chemical form,
so that, post radiolabelling, they may be used for tests on ani-
mals.
As we briefly mentioned, secondary neutrons from the pri-
mary reaction can be used to irradiate other targets for further
radioisotope production of the same or different type (e.g. Cu,
Sc, etc.). However, in this case, radiochemical methods are
needed to separate the medical radionuclides, as in the tradi-
tional production schemes (Smith (2012)).
From a financial point of view, material costs may be con-
siderably reduced, since the heavy (and usually rare) element
is used as the projectile (for instance, 70Zn has 0.6% natu-
ral abundance). Also, the radiochemical processing is sub-
stantially minimized or, desirably, completely eliminated be-
cause the radioisotope of interest is collected and essentially
used directly after production (and appropriate cooling). How-
ever, the primary requirement of our approach is the use of a
heavy-ion accelerator (e.g., cyclotron or LINAC) that can de-
liver high-intensity heavy-ion beams in the energy range 10–20
MeV/nucleon. Fortunately, such accelerators are available at a
number of facilities worldwide and, with appropriate planning,
a fraction of their beam time may be devoted to non-standard
radionuclide production following our inverse-kinematics ap-
proach.
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According to our estimates, with a primary beam of 1 parti-
cle µA, we can reach activities of 1.8 MBq/h and, thus, obtain
milliCurie quantities of 67Cu within 24 h of irradiation. The
pµA heavy-ion beam intensities are achievable with the current
ion-source and accelerator technology.
We note that the use of the cryogenic gas cell has the ad-
ditional advantage that its cooled windows can withstand the
necessary high beam currents. Appropriate circulation of the
cooled hydrogen gas will be necessary to mitigate the effect of
the local denstity reduction. For safe operation of the gas cell
under intense beam irradiation, even with thinner windows, we
may consider lowering the pressure to 1.0–1.5 atm, increasing
the length, and, furthermore, lowering the temperature below
LN2 temperatures with the use of modern cryocoolers [e.g., a
Gifford-McMahon refrigerator (Radebaugh (2009))].
Taking advantage of the development of thin liquids, it is
conceivable to substitute the hydrogen gas cell by a liquid H2
cell with thin windows. The development of a liquid H2/D2 tar-
get with typical thickness of a few mm is reported in (Jaeckle
(1994)). More recently, a liquid H2 target for fragmentation re-
actions has been reported in (Ryuto (2005)). This target was
operated at temperatures about 20 K, achieved with a Gifford-
McMahon refrigerator. The cell had a length of 30 mm and a
density of 200 mg/cm2. We propose the implementation of a
similar system for the production of medical isotopes, but for
this purpose the length has to be only 1-2 mm to achieve the
required thickness of about 8–10 mg/cm2.
In the case of the Cyclotron Institute of TAMU, the facil-
ity houses two cyclotrons: a) the K150 cyclotron which, in
principle, can produce high-intensity heavy-ion beams (up to
around Kr) with energies up to around 12–15 MeV/nucleon,
suitable for the production of relatively large activities of ra-
dioisotopes and, b) the K500 cyclotron, employed in the present
experiment, which can produce lower currents of heavy-ion
beams (upto 238U) and in a broader energy range (up to 20–
40 MeV/nucleon depending on the isotope). We anticipate
that both the K150 and the K500 cyclotrons may be success-
fully used for the development and production of a variety of
non-standard radioisotopes at activities appropriate for medical
studies on small animals. For this purpose, however, beams of
30–100 pnA have to be developed, which should be possible
with a modest investment at the existing ion-source and accel-
erator infrastructures.
To summarize, the aforementioned considerations for the de-
velopment of a viable route of medical radioisotope produc-
tion in inverse kinematics are based, first, on the successful re-
sults of the present study and, second, on the current experience
and developments on ion-source and accelerator technologies
worldwide. We think that a fruitful application of our proposed
method is acheivable with timely planning and allocation of
relatively modest resources. Along with the other production
approaches, the proposed route may contribute to a broad and
diversified program of production and use of non-standardmed-
ical radionuclides.
5. Conclusions
An innovative method for the production of important med-
ical radioisotopes was presented in this article. The approach
is based on realizing the nuclear reaction in inverse kinematics
by sending a heavy-ion beam of appropriate energy on a light
target (e.g., H, d, He) and collecting the isotope of interest on
an appropriate catcher after the target. In this work, as a proof-
of-principle, we studied the production of the radionuclide 67Cu
(T1/2=62 h) via the reaction of a beam of 15 MeV/nucleon
70Zn
with a cryogenic hydrogen gas target. The 67Cu radionuclide
(along with other coproduced isotopes) was collected after the
gas target on an Al catcher foil and the radioactivity was mea-
sured by off-line γ-ray analysis. After the end of the irradia-
tion, the main radioimpurity in the Al catcher coming from the
70Zn+p reaction was 69mZn (T1/2=13.8 h), which can be sup-
pressed by cooling for a period of 2–3 days. Other identified
radioimpurities are understood to come from the interaction of
the beam with the window material and the catcher and can
be eliminated by careful tuning of the parameters of the setup.
The present successful test and the ensuing considerations in-
dicate the possibility of producing important non-standard ra-
dionuclides of high radionuclide purity with the approach of
inverse kinematics. In parallel to the main production scheme,
secondary neutrons from the primary reaction were used to irra-
diate a secondary target of Zn for further radioisotope produc-
tion with promising results. The main requirement necessary to
achieve production of activities appropriate for preclinical stud-
ies is the availability of high-intensity (particle µA) heavy-ion
primary beams.
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